While successful vaccines exist for the common Zaire strain of Ebola, the current outbreak is caused by the different Bundibucho strain. This critical mismatch means there is no licensed vaccine available, forcing a complete restart of the scientific response and a race to develop a new, untested version from scratch.
In Eastern Congo, a third of the population doesn't believe Ebola is real. This deep-seated distrust of authorities and NGOs—often seen as self-serving—leads to violence against health workers and rejection of crucial safety measures, hampering containment more than logistical or medical challenges.
Despite sovereignty concerns, European firms find it impractical to switch from US "hyperscalers" like Microsoft or Google. The providers' integrated services, scale, and network effects (where customers and partners use the same systems) create a powerful lock-in that outweighs the desire for European alternatives.
Effective epidemic response requires a coordinated system across three areas: logistical field operations (testing, isolation), political will (funding, governance), and scientific innovation (vaccine development). A failure in any one of these distinct fronts cripples the entire effort to contain a disease outbreak.
A significant concern fueling Europe's push for tech sovereignty is the fear that America could use its tech dominance as a weapon, shutting off essential digital services during a political dispute. This "kill switch" narrative serves as a powerful political framing device to highlight the risks of dependency.
To retain European business, US cloud providers offer "sovereign" services, like air-gapped clouds, that appear to isolate EU data. However, critics label this "sovereign washing," arguing that since the parent companies are American, they remain subject to US laws like the Cloud Act, which can compel data access.
